The Janice Wiesman Young Investigator Grant Program

The Janice Wiesman Young Investigator Grant Program

Objective

The objective of the Janice Wiesman Young Investigator Grant Program is to provide funding to researchers at eligible academic or nonprofit institutions who submit innovative research proposals in the areas of translational, clinical, or applied research. The research should advance the understanding of ATTR amyloidosis, facilitate early diagnosis of patients with ATTR amyloidosis, and/or enhance management of patients with a diagnosis of ATTR amyloidosis. Specifically, this program will support two young investigators, such as current fellows, residents, or junior faculty, annually to promote quality research related to ATTR amyloidosis and to support the development of future researchers and clinicians.

Overview

Akcea’s Young Investigator Grant Program is named in honor of Dr. Janice Wiesman (1958-2020), a world expert on the neurological impact of amyloidosis who demonstrated remarkable commitment to and advancement of the field. This award will be granted on a competitive basis for a maximum of two academic years. The first year of the award is guaranteed, while the second year is contingent upon submission and approval of a progress report demonstrating both advancement towards the proposed research objectives and ongoing research. Applications for the Young Investigator Grant Program must be submitted in writing and will be reviewed by the review committee comprised of Medical Affairs and Compliance personnel. Applications will be assessed based on the scientific merit of the proposed research and the scientific qualifications of the applicant.

Deadlines and Important Dates

Young Investigator Award Funds

Eligibility and Qualifications 

Young Investigator Program Requirements

Application Materials

The following must be submitted via email to YoungInvestigator@akceatx.com to apply:

1. Award Request Letter
Must be on institutional letterhead, written and signed by the Department Chair, Division Chief, or Training Program Director and must include:

2. Current Curriculum Vitae or NIH Biosketch

3. Research Proposal (preferably not to exceed 5 pages)
Proposal to include:

4. Letter of Support from Mentor

OR, if investigator is not yet identified:

5. Formal Brochure/Overview of Training Program or Department

6. Vendor Set-up Form

Contact Information

For general questions about Akcea’s Young Investigator Grant Program, please contact us at YoungInvestigator@akceatx.com.

IONIS

Akcea Therapeutics has been acquired by Ionis Pharmaceuticals. For continued news and information about Akcea Therapeutics, please visit ionispharma.com. You are being redirected, please wait. If you have not been redirected in 30 seconds, please click the button below.

Go to ionispharma.com